PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.03%
EBIT growth of 43.03% while SMR.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
43.03%
Operating income growth of 43.03% while SMR.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
98.33%
Net income growth of 98.33% while SMR.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
98.37%
Positive EPS growth while SMR.AX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
98.37%
Positive diluted EPS growth while SMR.AX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
4.91%
Share change of 4.91% while SMR.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
4.91%
Diluted share change of 4.91% while SMR.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
59.77%
OCF growth of 59.77% while SMR.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
58.01%
FCF growth of 58.01% while SMR.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-100.00%
Negative 10Y revenue/share CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while SMR.AX stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
51.86%
OCF/share CAGR of 51.86% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
51.86%
OCF/share CAGR of 51.86% while SMR.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
51.86%
3Y OCF/share CAGR of 51.86% while SMR.AX is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
98.82%
10Y net income/share CAGR of 98.82% while SMR.AX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
98.82%
Net income/share CAGR of 98.82% while SMR.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
98.82%
Positive short-term CAGR while SMR.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.76%
Positive asset growth while SMR.AX is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.39%
We have a declining book value while SMR.AX shows 5.51%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.75%
We cut SG&A while SMR.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.